In the News

Share

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1731 News Items found
In the Clinic
MSK radiation oncologist and neuroblastoma expert Suzanne Wolden with a patient
Reduced Radiation for Neuroblastoma Could Lessen Children’s Side Effects Later

Learn how MSK doctors are exploring the use of less radiation in neuroblastoma treatment so children can avoid side effects.
a researcher holds a sign reading "Proud to be an MSK scientist"
Top Cancer Research Advances at MSK in 2023

Researchers at MSK pioneered many discoveries in 2023. Read about some of the most important findings.
Feature
Dr. Christopher Klebanoff
A New Type of Immunotherapy: MSK’s Christopher Klebanoff Is Fighting Cancer Cells From the Inside Out With T Cell Receptor (TCR) Therapy

Learn how MSK physician-scientist Christopher Klebanoff is working to bring immunotherapy to more patients, especially those with solid tumors.
MSK endometrial cancer specialists are seen: gynecological surgeon Carol Brown, MD; Carol Aghajanian, MD, Chief of the Gynecological Medical Oncology Service; medical oncologist Ying Liu, MD, MPH; and molecular geneticist Britta Weigelt, PhD.
Endometrial Cancer: New Insights Into a Deadly Disparity

Learn about new insights into endometrial cancer discovered by MSK experts, including why the growing rates of this cancer are even more dangerous for Black women.
Feature
Alicia Kalogeropoulos with her husband, Alex, at the beach.
Top Cancer Treatment Advances at MSK in 2023

Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2023. Read about some of the most important developments over the past year.
Feature
Dr. Miguel-Angel Perales
8 Reasons Why MSK Is a Leader in Stem Cell and Bone Marrow Transplants

The year 2023 marks the 50th anniversary of the first-ever transplant of bone marrow from a donor to a patient who was not related, which was performed at MSK. Here, Dr. Miguel-Angel Perales explains why MSK has continued to be a leader in the field of transplantation.
Patient receiving stereotactic body radiation therapy at Memorial Sloan Kettering Cancer Center.
Ablative Radiotherapy Controls Resistant Non-Small Cell Lung Cancer in Clinical Trial

Learn how highly focused, intense radiation can stop lung cancer from growing after it has spread to a small number of sites.
In the Clinic
Dr. Lorenzo Falchi
Blood Test To Identify Which Large B Cell Lymphoma Patients Are Candidates for Glofitamab Shows Promise in Clinical Trial

Learn about results from a clinical trial that found blood tests can help predict which patients with large B cell lymphoma are likely to benefit from the targeted therapy glofitamab (Columvi).
In the Clinic
Anne and Robert Schmiedel
New Treatment Results for Follicular Lymphoma Clinical Trial Presented at ASH 2023

A clinical trial of the targeted therapy mosunetuzumab (Lunsumio) has found this drug may help patients with follicular lymphoma avoid chemotherapy. Learn more about how it benefited patients who had not yet received other treatments for their lymphoma.
Omar Abdel-Wahab and Salima Benbarche
MSK’s Omar Abdel-Wahab Honored for Research Targeting Blood Cancers

MSK physician-scientist Dr. Omar Abdel-Wahab, is being honored at the 2023 American Society of Hematology (ASH) Annual Meeting with the William Dameshek Prize, which recognizes individuals who have made outstanding contributions to the field of hematology.